Biotechnological Advances in Tuberculosis Diagnosis: Global Developments and Their Applicability in Indonesia
Article Sidebar
Main Article Content
Page: 423-445
Abstract
Tuberculosis (TB) remains a major global health burden, and Indonesia is among the countries with the highest incidence and mortality rates. Early and accurate diagnosis is essential for effective TB control; however, conventional diagnostic methods such as sputum smear microscopy, culture, chest radiography, and the tuberculin skin test continue to face limitations in sensitivity, specificity, turnaround time, and operational feasibility. This narrative review synthesizes global biotechnological developments in TB diagnostics and evaluates their potential applicability within the Indonesian healthcare system. A structured literature search was conducted using PubMed, ScienceDirect, and Google Scholar, applying Population, Intervention, Comparison, and Outcome (PICO) based inclusion and exclusion criteria. Key advances in molecular diagnostics include conventional polymerase chain reaction (PCR), real-time PCR, automated nucleic acid amplification test (NAAT) platforms such as GeneXpert, Xpert Ultra, and Truenat, as well as loop-mediated isothermal amplification (LAMP). Emerging innovations including CRISPR-based assays, biosensor platforms, microfluidic lab-on-chip devices, and nanotechnology-enhanced systems demonstrate improved sensitivity, portability, and testing speed, with potential for point-of-care implementation, although many require further field-based validation. No single diagnostic tool is universally optimal, as suitability depends on infrastructure availability, workforce capacity, and population needs. In Indonesia, persistent challenges include limited laboratory networks, high diagnostic costs, supply-chain constraints, and variability in human resource competence. Strengthening diagnostic systems, expanding decentralized testing, integrating digital health technologies, and supporting local production of diagnostic materials are critical to enable sustainable adoption and accelerate progress toward national TB elimination targets.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
World Health Organization, Global tuberculosis report 2024. Geneva, 2024.
M. Z. Eriansyah, A. D. Ciptaningrum, T. P. P. Priyono, A. A. Putri, and R. Wasir, “Evaluation of Tuberculosis Control Strategy and Challenges in Indonesia After Pandemic COVID-19,” International Journal of Health Science, vol. 5, no. 2, pp. 1–37, 2025, doi: : https://doi.org/10.55606/ijhs.v5i2.509.
S. Mukherjee, S. Perveen, A. Negi, and R. Sharma, “Evolution of tuberculosis diagnostics: From molecular strategies to nanodiagnostics,” Tuberculosis, vol. 140, no. January, p. 102340, 2020, doi: https://doi.org/10.1016/j.tube.2023.102340.
A. D. Harries and A. M. V Kumar, “Challenges and Progress with Diagnosing Pulmonary Tuberculosis in Low and Middle-Income Countries,” Diagnostics, vol. 8, no. 78, pp. 1–14, 2018, doi: https://doi.org/10.3390/diagnostics8040078.
A. Calderaro, M. Buttrini, B. Farina, S. Montecchini, F. De Conto, and C. Chezzi, “Respiratory Tract Infections and Laboratory Diagnostic Methods: A Review with A Focus on Syndromic Panel-Based Assays,” Microorganisms, vol. 10, no. 1, p. 1856, 2022, doi: https://doi.org/10.3390/microorganisms10091856.
R. Sundari, B. Yinke, M. Sinaga, D. Elisabeth, and A. S. Wahyuni, “Comparison of Sensitivity and Specificity between Tuberculin Skin Test (TST) and Interferon-Gamma Release Assays (IGRA) for Latent TB Infection (LTBI) in Household Contacts of Drug-Sensitive TB Patients in Medan,” Jurnal Impresi Indonesia (JII), vol. 10, no. 1, pp. 2990–3001, 2023, doi: https://rivierapublishing.id/JII/index.php/jii/indexcomparison.
H. D. Shah et al., “Gaps and Interventions across the Diagnostic Care Cascade of TB Patients at the Level of Patient, Community and Health System: A Qualitative Review of the Literature,” Tropical Medicine and Infectious Disease, vol. 7, no. 136, pp. 1–14, 2022, doi: https://doi.org/10.3390/tropicalmed7070136.
M. Macgregor-fairlie, S. Wilkinson, G. S. Besra, and P. G. Oppenheimer, “Tuberculosis diagnostics: overcoming ancient challenges with modern solutions,” Emerging Topics in Life Sciences, vol. 4, no. November, pp. 435–448, 2020, doi: https://doi.org/10.1042/ETLS20200335.
W. Cao et al., “Recent advances in microbiological and molecular biological detection techniques of tuberculous meningitis,” Frontiers in Microbiology, vol. 14, no. August, pp. 1–13, 2023, doi: https://doi.org/10.3389/fmicb.2023.1202752.
R. L. Byrne et al., “Finding the missed millions: innovations to bring tuberculosis diagnosis closer to key populations,” BMC Global and Public Health, vol. 2, no. 33, pp. 1–9, 2024, doi: https://doi.org/10.1186/s44263-024-00063-4.
M. J. Page et al., “PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews,” Research Methods and Reporting PRISMA, vol. 5, no. 1, p. 372, 2021, doi: https://doi.org/10.1136/bmj.n160.
D. M. Lewinsohn et al., “Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children,” HHS Public Access, vol. 64, no. 2, pp. 111–115, 2017, doi: https://doi.org/10.1093/cid/ciw778.
N. Zaporojan, R. A. Negrean, R. Hodisan, C. Zaporojan, A. Csep, and D. C. Zaha, “Evolution of Laboratory Diagnosis of Tuberculosis,” Clinics and Practice, vol. 14, no. 1, pp. 388–416, 2024, doi: https://doi.org/10.3390/clinpract14020030.
A. J. Caulfield and N. L. Wengenack, “Diagnosis of active tuberculosis disease: From microscopy to molecular techniques,” Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, vol. 4, no. 1, pp. 33–43, 2016, doi: http://dx.doi.org/10.1016/j.jctube.2016.05.005.
M. A. Zeru, “Prevalence and associated factors of HIV-TB co-infection among HIV patients: a retrospective Study,” African Health Sciences, vol. 21, no. 3, pp. 1003–1009, 2021, doi: https://dx.doi.org/10.4314/ahs.v21i3.7.
N. Gizaw et al., “The yield of Auramine O staining using led microscopy with bleach treated sputum samples for detection of pulmonary tuberculosis at St . Peter tuberculosis specialized hospital, Addis Ababa, Ethiopia,” Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, vol. 18, no. 1, p. 100140, 2020, doi: https://doi.org/10.1016/j.jctube.2019.100140.
A. Karuniawati et al., “Performance of Xpert MTB/RIF and sputum microscopy compared to sputum culture for diagnosis of tuberculosis in seven hospitals in Indonesia,” Frontiers in Medicine, vol. 9, no. January, pp. 1–10, 2023, doi: https://doi.org/10.3389/fmed.2022.909198.
I. Afsar, M. Gunes, H. Er, and A. G. Sener, “Comparison of culture, microscopic smear and molecular methods in diagnosis of tuberculosis,” Sociedad Española de Quimioterapia, vol. 31, no. 5, pp. 435–438, 2018, doi: https://doi.org/10.5812/jjm.8939.
W. Indrasari, I. Kurniati, A. Dermawan, and H. I. Sufa, “Confirmation of Mycobacterium tuberculosis culture results with Ziehl-Neelsen staining and MPT64 antigen test,” Current Biomedicine, vol. 3, no. 1, pp. 11–15, 2025, doi: https://doi.org/10.29244/currbiomed.3.1.11.
K. K. Chopra and S. Singh, “Newer Diagnostic tests for tuberculosis, their utility and their limitations,” Current Medicine Research and Practice, vol. 10, no. 1, pp. 8–11, 2020, doi: https://doi.org/10.1016/j.cmrp.2020.01.004.
A. Spoladori et al., “Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches Guilherme,” Diseases, vol. 12, no. 1, pp. 1–24, 2024, doi: https://doi.org/10.3390/diseases12090202.
M. Nel, Z. Franckling-smith, T. Pillay, S. Andronikou, and H. J.Zar, “Chest Imaging for Pulmonary TB-An Update,” Pathogens, vol. 11, no. 1, pp. 1–15, 2022, doi: https://doi.org/10.3390/pathogens11020161.
D. S. Singini et al., “Clinical diagnosis of TB: lessons on misdiagnosis and overdiagnosis,” Public Health Action, vol. 15, no. 2, pp. 93–95, 2025, doi: http://dx.doi.org/10.5588/pha.25.0012 Clinically.
A. S. Bhalla, A. Goyal, R. Guleria, and A. K. Gupta, “Chest tuberculosis: Radiological review and imaging recommendations,” Indian Journal of Radiology and Imaging, vol. 25, no. 3, pp. 213–225, 2015, doi: https://doi.org/10.4103/0971-3026.161431.
A. J. Arumairaj et al., “Determining the Need for Additional Testing With Quantiferon TB Gold in Patients With Positive Tuberculin Skin Tests and a History of BCG Vaccination,” Cureus, vol. 15, no. May, pp. 1–8, 2023, doi: https://doi.org/10.7759/cureus.39272.
J. A. Santos, R. Duarte, and C. Nunes, “Tuberculin skin test and predictive host factors for false-negative results in patients with pulmonary and extrapulmonary tuberculosis,” The Clinical Respiratory Journal, vol. 14, no. September, pp. 541–548, 2020, doi: https://doi.org/10.1111/crj.13166.
M. A. Tobaiqi, M. N. Alshamrani, S. Sriram, A. B. Mahmoud, H. A. Fadlalmola, and M. Albadrani, “Interferon-Gamma Release Assays Versus Tuberculin Skin Test for Active Tuberculosis Diagnosis: A Systematic Review and Diagnostic Meta-Analysis,” Diagnostics, vol. 15, no. 1, pp. 1–25, 2025, doi: https://doi.org/10.3390/diagnostics15182343.
E. Maclean et al., “Advances in Molecular Diagnosis of Tuberculosis,” Journal of Clinical Microbiology, vol. 58, no. September, pp. 1–13, 2020, doi: https://doi.org/10.1128/JCM.01582-19.
H. Meghdadi, A. D. Khosravi, A. A. Ghadiri, A. H. Sina, and A. Alami, “Detection of Mycobacterium tuberculosis in extrapulmonary biopsy samples using PCR targeting IS 6110, rpoB, and nested-rpoB PCR Cloning,” Frontiers in Microbiology, vol. 6, no. July, pp. 1–8, 2015, doi: https://doi.org/10.3389/fmicb.2015.00675.
M. A. Lyra et al., “Evaluation of four molecular methods for the diagnosis of tuberculosis in pulmonary and blood samples from immunocompromised patients,” The Memórias do Instituto Oswaldo Cruz, vol. 109, no. September, pp. 805–813, 2014, doi: https://doi.org/10.1590/0074-0276130542.
H. Caiaffa-filho et al., “Preanalytical Conditions Can Interfere with M.Tuber-Culosis Detection by PCR in Respiratory Samples,” Clinics, vol. 73, no. 12, pp. 1–6, 2018, doi: https://doi.org/10.6061/clinics/2017/e410.
Z. Lv, M. Zhang, H. Zhang, and X. Lu, “Utility of Real-Time Quantitative Polymerase Chain Reaction in Detecting Mycobacterium tuberculosis,” BioMed Research International, vol. 5, no. 1, p. 1058579, 2017, doi: https://doi.org/10.1155/2017/1058579.
A. S. Rodriguez-Pazmino et al., “Conventional DNA Extraction Followed by Real-Time PCR Had Higher Sensitivity for Detection of Mycobacterium Tuberculosis in Clinical Samples Compared to Standard Methods,” The American Journal of Tropical Medicine and Hygiene, vol. 112, no. 6, pp. 1260–1263, 2025, doi: https://doi.org/10.4269/ajtmh.24-0797.
S. E. Dorman et al., “Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study,” The Lancet Infectious Diseases, vol. 18, no. January, pp. 76–84, 2018, doi: https://doi.org/10.1016/S1473-3099(17)30691-6.
S. Yadav, G. Rawal, M. Jeyaraman, and N. Jeyaraman, “Advancements in Tuberculosis Diagnostics: A Comprehensive Review of the Critical Role and Future Prospects of Xpert MTB/RIF Ultra Technology,” Cureus, vol. 16, no. 3, p. e57311, 2024, doi: https://doi.org/10.7759/cureus.57311.
N. S. Gomathi et al., “Multicentric validation of indigenous molecular test TruenatTM MTB for detection of Mycobacterium tuberculosis in sputum samples from presumptive pulmonary tuberculosis patients in comparison with reference standards,” Indian Journal of Medical Research, vol. 152, no. October, pp. 378–385, 2020, doi: https://doi.org/10.4103/ijmr.IJMR_2539_19.
C. F. Hanrahan and M. Shah, “Economic challenges associated with tuberculosis diagnostic development,” Expert Review of Pharmacoeconomics & Outcomes Research, vol. 14, no. 4, pp. 499–510, 2015, doi: https://doi.org/10.1586/14737167.2014.914438.Economic.
J. Park, “Principles and Applications of Loop-Mediated Isothermal Amplification to Point-of-Care Tests,” Biosensors, vol. 12, no. 10, p. 857, 2022, doi: https://doi.org/10.3390/bios12100857.
Y. Hassan, L. Thian, and L. Than, “Loop-Mediated Isothermal Amplification (LAMP): Comparative Advances over Conventional PCR and Other Molecular Techniques,” Annual Research & Review in Biology, vol. 35, no. August, pp. 33–44, 2020, doi: https://doi.org/10.9734/ARRB/2020/v35i830257.
M. Zaber, F. Hoque, I. Monir, and S. Tarafder, “Evaluation of Multiplex loop-mediated isothermal amplification assay for the detection of Mycobacterium tuberculosis complex from clinically suspected cases of pulmonary tuberculosis,” Heliyon, vol. 10, no. May, p. e39847, 2024, doi: https://doi.org/10.1016/j.heliyon.2024.e39847.
M. Irfan and D. Bisht, “Innovations in Molecular Identification of Mycobacterium tuberculosis,” Journal of Pure and Applied Microbiology, vol. 16, no. March, pp. 74–88, 2022, doi: https://doi.org/10.22207/JPAM.16.1.76.
R. Z. Eddine, G. Refrégier, J. Cervantes, and N. K. Yokobori, “The future of CRISPR in Mycobacterium tuberculosis infection,” Journal of Biomedical Science, vol. 30, no. 1, pp. 1–12, 2023, doi: https://doi.org/10.1186/s12929-023-00932-4.
J. Ai et al., “CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis,” Emerging Microbes & Infections, vol. 8, no. 1, pp. 1361–1369, 2019, doi: https://doi.org/10.1080/22221751.2019.1664939.
A. Kaushik, Y. Saini, Z. Fatima, J. Singh, and H. Saif, “Exploring the diagnostic synergy of isothermal amplification-integrated CRISPR technology for tuberculosis: a systematic review,” Sensors & Diagnostics, vol. 4, no. 1, pp. 823–832, 2025, doi: https://doi.org/10.1039/d5sd00080g.
A. Ghouneimy, A. Mahas, T. Marsic, R. Aman, and M. Mahfouz, “CRISPR-Based Diagnostics: Challenges and Potential Solutions toward Point-of-Care Applications,” ACS Synthetic Biology, vol. 12, no. 1, pp. 1–16, 2023, doi: https://doi.org/10.1021/acssynbio.2c00496.
Z. Huang, G. Zhang, C. J. Lyon, T. Y. Hu, and S. Lu, “Outlook for CRISPR-based tuberculosis assays now in their infancy,” Frontiers in Immunology, vol. 14, no. August, pp. 1–9, 2023, doi: https://doi.org/10.3389/fimmu.2023.1172035.
Z. Zhou, I. Cho, and U. S. Kadam, “CRISPR-Cas-Based Diagnostics in Biomedicine: Principles, Applications, and Future Trajectories,” Biosensors, vol. 15, no. 10, pp. 1–38, 2025, doi: https://doi.org/10.3390/ bios15100660.
Y. Qi et al., “CRISPR-Based Diagnostics: A Potential Tool to Address the Diagnostic Challenges of Tuberculosis,” Pathogens, vol. 11, no. 12, pp. 1–6, 2022, doi: https://doi.org/10.3390/ pathogens11101211.
G. Seo et al., “Ultrasensitive biosensing platform for Mycobacterium tuberculosis detection based on functionalized graphene devices,” Frontiers in Bioengineering and Biotechnology, vol. 11, no. December, pp. 1–10, 2023, doi: https://doi.org/10.3389/fbioe.2023.1313494.
B. Golichenari et al., “Electrochemical-based biosensors for detection of Mycobacterium tuberculosis and tuberculosis biomarkers,” Critical Reviews in Biotechnology, vol. 8551, no. 9, pp. 1–22, 2019, doi: https://doi.org/10.1080/07388551.2019.1668348.
M. Singh, C. S. Sreelakshmi, C. Mukhopadhyay, S. D. George, P. Nag, and K. Sadani, “Advances in optical biosensors as alternative diagnostics for clinical determination of ESKAPE bacteria,” Sensors and Actuators Reports journal, vol. 10, no. May, pp. 1–22, 2025, doi: https://doi.org/10.1016/j.snr.2025.100365.
P. Skládal, “Piezoelectric biosensors: shedding light on principles and applications,” Microchimica Acta, vol. 191, no. 184, pp. 1–13, 2024, doi: https://doi.org/10.1007/s00604-024-06257-9.
Y. Hang, A. Wang, and N. Wu, “Plasmonic silver and gold nanoparticles: shape and structure modulated plasmonic functionality for point-of-caring sensing, bio-imaging and medical therapy,” Chemical Society Reviews, vol. 53, no. 6, pp. 2932–2971, 2025, doi: https://doi.org/10.1039/d3cs00793f.
K. M. Joshi et al., “Advancing protein biosensors: redefining detection through innovations in materials, mechanisms, and applications for precision medicine and global diagnostics,” Royal Society of Chemistry Advances, vol. 15, no. 1, pp. 11523–11536, 2025, doi: https://doi.org/10.1039/d4ra06791f.
M. Parihar, W. N. Niharika, R. Biswas, B. Dehury, and N. Mazumder, “Point-of-care biosensors for infectious disease diagnosis: recent updates and prospects,” Royal Society of Chemistry Advances, vol. 15, no. 1, pp. 29267–29283, 2025, doi: https://doi.org/10.1039/d5ra03897a.
H. Joshi, D. Kandari, S. S. Maitra, and R. Bhatnagar, “Biosensors for the detection of Mycobacterium tuberculosis: a comprehensive overview,” Critical Reviews in Microbiology, vol. 10, no. 1, pp. 1–29, 2022, doi: https://doi.org/10.1080/1040841X.2022.2035314.
A. Mobed et al., “Biosensors; nanomaterial-based methods in diagnosing of Mycobacterium tuberculosis,” Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, vol. 34, no. December 2023, pp. 1–12, 2024, doi: https://doi.org/10.1016/j.jctube.2023.10041.
Y. Xie, L. Dai, and Y. Yang, “Microfluidic technology and its application in the point-of-care testing field,” Biosensors and Bioelectronics, vol. 10, no. December, pp. 1–13, 2022, doi: https://doi.org/10.1016/j.biosx.2022.100109.
C. M. Moore et al., “A Novel Microfluidic Dielectrophoresis Technology to Enable Rapid Diagnosis of Mycobacteria tuberculosis in Clinical Samples,” The Journal of Molecular Diagnostics, vol. 25, no. 7, pp. 514–523, 2023, doi: https://doi.org/10.1016/j.jmoldx.2023.04.005.
K. Fibben, E. K. Williams, J. D. Roback, W. A. Lam, and D. N. Alter, “From Lab-on-a-Chip to Lab-on-a-Chip-in-the-Lab: a perspective of clinical laboratory medicine for the microtechnologist,” Lab on a Chip, vol. 25, no. 1, pp. 2566–2577, 2025, doi: https://doi.org/10.1039/d4lc00614c.
S. Sathish and A. Q. Shen, “Toward the Development of Rapid, Specific, and Sensitive Microfluidic Sensors: A Comprehensive Device Blueprint,” Journal of the American Chemical Society Au, vol. 1, no. 1, pp. 1815–1833, 2021, doi: https://doi.org/10.1021/jacsau.1c00318.
C. Wang, M. Liu, Z. Wang, S. Li, Y. Deng, and N. He, “Point-of-care diagnostics for infectious diseases: From methods to devices,” Nano Today, vol. 37, no. January, pp. 2–53, 2020, doi: https://doi.org/10.1016/j.nantod.2021.101092.
A. K. Gupta, A. Sing, and Singh Sarman, “Diagnosis of Tuberculosis: Nanodiagnostics Approaches,” NanoBioMedicine, vol. 10, no. 1, pp. 261–283, 2019, doi: https://doi.org/10.1007/978-981-32-9898-9_11.
X. Ma et al., “Nanotechnology in healthcare, and its safety and environmental risks,” Journal of Nanobiotechnology, vol. 22, no. 715, pp. 1–81, 2024, doi: https://doi.org/10.1186/s12951-024-02901-x.
N. T. Le, T. J. M. Boskovic, M. M. Allard, K. E. Nick, S. R. Kwon, and C. C. Perry, “Gold Nanostar Characterization by Nanoparticle Tracking Analysis,” ACS Omega, vol. 7, no. 1, pp. 44677–44688, 2022, doi: https://doi.org/10.1021/acsomega.2c03275.
X. Yang et al., “Current progress of functional nanobiosensors for potential tuberculosis diagnosis: The novel way for TB control?,” Frontiers in Bioengineering and Biotechnology, vol. 10, no. December, pp. 1–18, 2022, doi: https://doi.org/10.3389/fbioe.2022.1036678.
Z. Zhang, Y. Cong, Y. Huang, and X. Du, “Nanomaterials-Based Electrochemical Immunosensors,” Micromachines, vol. 10, no. 6, p. 397, 2019, doi: https://doi.org/10.3390/mi10060397.
J. Zhu, H. Wang, and L. Chen, “Recent advances in nanomaterials for the detection of mycobacterium tuberculosis (Review),” International Journal of Molecular Medicine, vol. 55, no. 36, pp. 1–17, 2025, doi: https://doi.org/10.3892/ijmm.2024.5477.
A. Shrivas and S. Singh, “Tuberculosis Diagnosis and Management: Recent Advances,” Journal of Global Infectious Diseases, vol. 17, no. March, pp. 3–9, 2025, doi: https://doi.org/10.4103/jgid.jgid_112_24.
B. Zribi et al., “A microfluidic electrochemical biosensor based on multiwall carbon nanotube/ferrocene for genomic DNA detection of Mycobacterium tuberculosis in clinical isolates,” Biomicrofluidics, vol. 10, no. 1, p. 014115, 2016, doi: https://doi.org/10.1063/1.4940887.
A. L. García-basteiro et al., “Point of care diagnostics for tuberculosis,” Pulmonology, vol. 24, no. 2, pp. 73–85, 2018, doi: https://doi.org/10.1016/j.pulmoe.2017.12.002.
S. Brown, J. E. Leavy, and J. Jancey, “Implementation of GeneXpert for TB Testing in Low- and Middle-Income Countries: A Systematic Review,” Global Health: Science and Practice 2021, vol. 9, no. 3, pp. 698–710, 2021, doi: https://doi.org/10.9745/GHSP-D-21-00121.
R. Subbaraman et al., “Constructing care cascades for active tuberculosis: A strategy for program monitoring and identifying gaps in quality of care,” PLoS Medicine, vol. 16, no. 2, pp. 1–18, 2019, doi: https://doi. org/10.1371/journal.pmed.1002754.
I. Kementerian Kesehatan, Laporan hasil studi inventori tuberkulosis indonesia 2023-2024. Indonesia: Kementerian Kesehatan RI, 2024.
W. World Health Organization, Implementing The End TB Strategy: The Essentials. 2022.
R. D. Pratiwi, B. Alisjahbana, Y. W. Subronto, S. Priyanta, and S. Suharna, “Implementation of an information system for tuberculosis in healthcare facilities in Indonesia: evaluation of its effectiveness and challenges,” Archives of Public Health, vol. 83, no. 22, pp. 1–18, 2025, doi: https://doi.org/10.1186/s13690-025-01507-5.
D. W. Dowdy, “Minding the Gap: Specimen Referral Systems for Diagnosis of Infectious Diseases,” Clinical Infectious Diseases, vol. 64, no. 1, pp. 804–805, 2017, doi: https://doi.org/10.1093/cid/ciw820.
R. Crowder et al., “Diagnostic Accuracy of Tuberculosis Screening Tests in a Prospective Multinational Cohort: Chest Radiography With Computer-Aided Detection, Xpert Tuberculosis Host Response, and C-Reactive Protein,” Clinical Infectious Diseases, vol. 54, no. 9, pp. 1–9, 2022, doi: https://doi.org/10.1093/cid/ciae549.
A. J. Meyer et al., “Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda,” PLoS ONE, vol. 12, no. 7, pp. 1–12, 2017, doi: https://doi.org/10.1371/journal. pone.0180572.
A. Y. Soeroto et al., “Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study,” PLoS ONE, vol. 14, no. 2, pp. 1–16, 2019, doi: https://doi.org/10.1371/journal. pone.0213017.
H. Albert et al., “Optimizing diagnostic networks to increase patient access to TB diagnostic services: Development of the diagnostic network optimization (DNO) approach and learnings from its application in Kenya, India and the Philippines,” PLoS ONE, vol. 18, no. 11, pp. 1–14, 2023, doi: https://doi.org/10.1371/journal. pone.0279677.
V. Nikolayevskyy et al., “External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study,” PLoS ONE, vol. 11, no. 4, pp. 1–14, 2016, doi: https://doi.org/10.1371/journal.pone.0152926.
M. Abasivani, S. K. Foroushan, R. Khayami, and A. Sahebkar, “Mycobacterium tuberculosis Detection Using CRISPR Technology: An Updated Systematic Review and Meta-analysis,” Molecular Diagnosis & Therapy, vol. 28, no. 1, pp. 777–790, 2024, doi: https://doi.org/10.1007/s40291-024-00741-x.
J. G. Majamanda, C. M. Hosseinipour, M. B. Chagomerana, P. Munyewende, and N. Ndlovu, “Barriers to GeneXpert utilization for tuberculosis detection at a regional referral hospital in Malawi: a qualitative study a qualitative study,” Pan African Medical Journal, vol. 50, no. 59, pp. 1–12, 2025, doi: https://doi.org/10.11604/pamj.2025.50.59.31398.
D. Amare et al., “Effectiveness of healthcare workers and volunteers training on improving tuberculosis case detection: A systematic review and meta-analysis,” PLoS ONE, vol. 18, no. 3, pp. 1–13, 2023, doi: https://doi.org/10.1371/journal. pone.0271825.
D. Pamba et al., “Tuberculosis service delivery challenges and their mitigations during the 19 pandemic in Tanzania: a qualitative study,” BMJ Open, vol. 15, no. 1, pp. 1–9, 2025, doi: https://doi.org/10.1136/bmjopen-2024-094564.
K. K. Htwe et al., “Pre-treatment loss to follow-up and treatment delay among bacteriologically-confirmed tuberculosis patients diagnosed in Mandalay Region, Myanmar,” Tropical Medicine and Health, vol. 9, no. 1, pp. 1–10, 2019, doi: https://doi.org/10.1186/s41182-019-0154-9.
R. KEMENKES, Peraturan Menteri Kesehatan Republik Indonesia Nomor 3 Tahun 2023, no. 35. Indonesia, 2023.
R. KEMENKES, Peraturan menteri kesehatan republik indonesia nomor 26 tahun 2021. Indonesia, 2021.
National TB Program, Indonesia Digital TB Surveillance System Assessment Report. Indonesia, 2022.
S. Saragih et al., “Estimating the budget impact of a Tuberculosis strategic purchasing pilot study in Medan, Indonesia (2018-2019),” Health Economics Review, vol. 14, no. 44, pp. 1–11, 2024, doi: https://doi.org/10.1186/s13561-024-00518-2.
F. Aulia, Helda, and H. N. G. Djadjuli, “Evaluation of the Tuberculosis Surveillance System in Depok, West Java,” Medical and Health Science Journal, vol. 9, no. 1, pp. 30–39, 2025, doi: https://doi.org/10.33086/mhsj.v9i1.6968.
M. Pai, M. P. Nicol, and C. C. Boehme, “Tuberculosis Diagnostics: State of the Art and Future Directions,” Microbiology Spectrum, vol. 4, no. 59, pp. 1–15, 2016, doi: https://doi.org/10.1128/microbiolspec.
Z. Yang et al., “Recent progress in tuberculosis diagnosis: insights into blood-based biomarkers and emerging technologies,” Frontiers in Cellular and Infection Microbiology, vol. 15, no. May, pp. 1–18, 2025, doi: https://doi.org/10.3389/fcimb.
Y. Jiang et al., “Development and clinical validation of a novel multiplex PCR test for detection of respiratory pathogens via fluorescence melting curve analysis,” Scientific Reports, vol. 15, no. 1, pp. 1–8, 2025, doi: https://doi.org/10.1038/s41598-025-16434-2.
H. Chopra et al., “An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management,” Pharmaceuticals, vol. 16, no. 1, p. 581, 2023, doi: https://doi.org/10.3390/ ph16040581.
C. Dong, Y. Liu, J. Nie, X. Zhang, F. Yu, and Y. Zhou, “Artificial Intelligence in Infectious Disease Diagnostic Technologies,” Diagnostics, vol. 15, no. 1, pp. 1–20, 2025, doi: https://doi.org/ 10.3390/diagnostics15202602.
M. Lukman, W. Rakhmawati, and Rositianti., “Health Service Contracting in the Prevention and Treatment of Tuberculosis: A Scoping Review,” Journal of Multidisciplinary Healthcare, vol. 18, no. 10, pp. 6955–6964, 2025, doi: https://doi.org/10.2147/JMDH.S547815.